中广核技(000881) - 2025 Q2 - 季度业绩预告

Estimated Performance for the Current Period The company projects a net loss attributable to shareholders for H1 2025, with non-recurring net loss expected to narrow compared to the prior year - The performance forecast covers the period from January 1, 2025, to June 30, 2025[2] Key Financial Performance Indicators | Item | Current Period (Jan 1 - Jun 30, 2025) | Prior Period | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | Loss: RMB 90.00 million to RMB 120.00 million | Loss: RMB 86.5778 million | | Net Profit After Non-Recurring Items | Loss: RMB 100.00 million to RMB 130.00 million | Loss: RMB 131.4708 million | | Basic Earnings Per Share | Loss: RMB 0.0952/share to RMB 0.1269/share | Loss: RMB 0.0916/share | Communication with Accounting Firm The performance forecast data is a preliminary estimate by the company and has not been audited by a certified public accountant - This performance forecast has not been audited by a certified public accountant[3] Explanation of Performance Changes Despite growth in new materials, overall performance fell short due to increased R&D investment in early-stage medical health and silicon photomultiplier businesses, temporary losses in accelerator operations, and a significant decrease in non-recurring government subsidies - Overall company performance fell short of expectations, primarily impacted by the following business areas: - Medical Health Business: Still in its early industrialization phase, current period losses expanded year-over-year due to increased investment in proton therapy equipment market expansion, core technology R&D, and isotope business layout[4] - Silicon Photomultiplier Business: In its incubation phase, it has not yet achieved profitability due to continuous investment in independent breakthroughs for critical product components and improvements in production line yield[4] - Accelerator and Irradiation Business: Due to adjustments in some client delivery schedules, the number of accelerator deliveries decreased year-over-year, resulting in a temporary loss during the reporting period[5] - Non-Recurring Gains and Losses: Government subsidies recognized in current period profit and loss significantly decreased year-over-year, leading to a substantial decline in non-recurring items compared to the prior period[5] Risk Warning The company advises that this performance forecast is preliminary, and final financial data will be based on the officially disclosed 2025 semi-annual report, cautioning investors about investment risks - This performance forecast is a preliminary estimate, and the specific financial data will be subject to the company's upcoming 2025 semi-annual report[6]